Characterization of soluble thrombomodulin levels in patients with stage 3–5 chronic kidney disease

Inflammation and coagulation in atherosclerosis

(2013) K. A. Krychtiuk et al.   Hamostaseologie

The risk of atherosclerosis in patients with chronic kidney disease

(2013) Sylwia Olechnowicz-Tietz et al.   INTERNATIONAL UROLOGY AND NEPHROLOGY

Progressive Increase of Inflammatory Biomarkers in Chronic Kidney Disease and End-Stage Renal Disease

(2012) Korosh Sharain et al.   CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS

Thrombomodulin Links Coagulation to Inflammation and Immunity

(2012) John Morser   CURRENT DRUG TARGETS

Serum Thrombomodulin as a Newly Identified Biomarker for Postoperative Lung Injury: A Prospective Observational Study

(2012) Sumiko Maeda et al.   TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE

Thrombomodulin and its role in inflammation

(2011) Edward M. Conway   Seminars in Immunopathology

CRP Polymorphisms and Progression of Chronic Kidney Disease in African Americans

(2009) A. M. Hung et al.   Clinical Journal of the American Society of Nephrology

Soluble Thrombomodulin Protects Ischemic Kidneys

(2009) A. A. Sharfuddin et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Aspects of Immune Dysfunction in End-stage Renal Disease

(2008) S. Kato et al.   Clinical Journal of the American Society of Nephrology

Allergen-enhanced thrombomodulin (blood dendritic cell antigen 3, CD141) expression on dendritic cells is associated with a TH2-skewed immune response

(2008) Stephanie T. Yerkovich et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY